Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

3
results for

"DILI"

Article category

Keywords

Publication year

"DILI"

Original Article

Plasma lipidomics and fungal peptide-based community analysis identifies distinct signatures for early mortality in acute liver failure
Neha Sharma, Sushmita Pandey, Gaurav Tripathi, Manisha Yadav, Nupur Sharma, Babu Mathew, Abhishak Gupta, Vasundhra Bindal, Sadam H. Bhat, Yash Magar, Rimsha Saif, Sanju Yadav, Amritpal Kaur, Rakhi Maiwall, Shvetank Sharma, Shiv Kumar Sarin, Jaswinder Singh Maras
Clin Mol Hepatol 2025;31(4):1233-1251.
Published online December 13, 2024
DOI: https://doi.org/10.3350/cmh.2024.0554
Background/Aims
Acute liver failure (ALF) has high mortality predominantly due to compromised immune system and increased vulnerability to bacterial and fungal infections.
Methods
Plasma lipidome and fungal peptide-based community (mycobiome) analysis were performed in discovery cohort (ALF=40, healthy=5) and validated in a validation cohort of 230 patients with ALF using high-resolution-mass-spectrometry, artificial neural network (ANN) and machine learning (ML).
Results
Untargeted lipidomics identified 2,013 lipids across 8 lipid group. 5 lipid-species—phosphatidylcholine (PC)[15:0/17:0], PC[20:1/14:1], PC[26:4/10:0], PC[32:0] and TG[4:0/10:0/23:6]—significantly differentiated ALF-NS (FC>10, P<0.05, FDR<0.01). Mycobiome alpha/beta diversity was significantly higher and showed 4 phyla and >20 species significantly dysregulated in ALF-NS linked with lipid metabolism, fatty acid elongation in ER, and others (P<0.05). Lipid and mycobiome diversity values in ALF-NS were strongly correlated (r2>0.7, P<0.05). Multi-modular correlation network showed striking associations between lipid, fungal peptide modules, and clinical parameters specific to ALF-NS (P<0.05). Cryptococcus amylolentus CBS6039 and Penicillium oxalicum 1142 directly correlated with phosphatidylcholine, triglycerides, and severity in ALF-NS (r2>0.85, P<0.05). POD-fungus and POD-lipids showed direct association with infection, necrosis, and hepatic encephalopathy (Beta>1.2, P<0.05). POD-lipid (AUC=0.969 and HR=1.99 [1.02–2.04]) superseded POD-fungus and severity indices for early-mortality prediction. Finally, significant increase in PC (15:0/17:0) level showed highest normalized importance, and ANNs and ML predicted early mortality with >95% accuracy, sensitivity, and specificity. Interestingly, fungal surveillance protein Clec7a was significantly downregulated (>2-fold), leading to a notable increase in fungal infection-mediated choline/phosphatidylcholine and associated enzymes (FC>1.5; Kennedy cycle). This contributed to phosphatidic acid-mediated hyper-inflammation in ALF-NS.
Conclusions
In ALF, the plasma lipidome and mycobiome are dysregulated. Increased circulating phosphatidylcholine could stratify ALF predisposed to early mortality or require emergency liver transplantation.
  • 9,439 View
  • 260 Download

Case Report

Drug induced liver injury

Drug-induced liver injury caused by iodine-131
Chei Won Kim, Ji Sun Park, Se Hwan Oh, Jae-Hyung Park, Hyun-Ik Shim, Jae Woong Yoon, Jin Seok Park, Seong Bin Hong, Jun Mi Kim, Trong Binh Le, Jin Woo Lee
Clin Mol Hepatol 2016;22(2):272-275.
Published online May 20, 2016
DOI: https://doi.org/10.3350/cmh.2015.0037
Iodine-131 is a radioisotope that is routinely used for the treatment of differentiated thyroid cancer after total or near-total thyroidectomy. However, there is some evidence that iodine-131 can induce liver injury . Here we report a rare case of drug-induced liver injury (DILI) caused by iodine-131 in a patient with regional lymph node metastasis after total thyroidectomy. A 47-year-old woman was admitted with elevated liver enzymes and symptoms of general weakness and nausea. Ten weeks earlier she had undergone a total thyroidectomy for papillary thyroid carcinoma and had subsequently been prescribed levothyroxine to reduce the level of thyroid-stimulating hormone. Eight weeks after surgery she underwent iodine-131 ablative therapy at a dose of 100 millicuries, and subsequently presented with acute hepatitis after 10 days. To rule out all possible causative factors, abdominal ultrasonography, endoscopic ultrasonography (on the biliary tree and gall bladder), and a liver biopsy were performed. DILI caused by iodine-131 was suspected. Oral prednisolone was started at 30 mg/day, to which the patient responded well.

Citations

Citations to this article as recorded by  Crossref logo
  • Protective Role of Vitamin D in Attenuating RAI-Induced Liver Injury in Rats
    Muzaffer Atli, Aylin Akbulut, Serdar Kuru, Nadide Koca, Koray Demirel, Gökhan Koca, Mehmet Şeneş, Nihat Yumuşak, Meliha Korkmaz
    Bratislava Medical Journal.2025;[Epub]     CrossRef
  • Hepatotoxicity of iodine-131 ablation for post-surgical differentiated thyroid cancer patients with hepatitis B virus infection
    Zhishuo Mo, Ziying Lei, Peipei Wang, Zhebin Wu, Haijuan Yuan, Dongying Xie, Zeqian Wu, Zenan Huang
    Clinics and Research in Hepatology and Gastroenterology.2021; 45(6): 101631.     CrossRef
  • Challenges in early identification of causes and treatment of cholestasis in patients with hyperthyroidism: a case report and literature review
    Baimei Zeng, Ling Yuan, Jun Chu, Yanqing Yang, Shide Lin
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • The interplay between thyroid and liver: implications for clinical practice
    E. Piantanida, S. Ippolito, D. Gallo, E. Masiello, P. Premoli, C. Cusini, S. Rosetti, J. Sabatino, S. Segato, F. Trimarchi, L. Bartalena, M. L. Tanda
    Journal of Endocrinological Investigation.2020; 43(7): 885.     CrossRef
  • Perioperative considerations of hyperthyroidism in a patient with liver failure: case report
    Byung Hwa Kim, Yun Hee Kim, Yoon Sook Lee, Woon Young Kim, Jae Hwan Kim
    Medical Biological Science and Engineering.2019; 2(2): 60.     CrossRef
  • Recent Advances in the Histopathology of Drug-Induced Liver Injury
    David E. Kleiner
    Surgical Pathology Clinics.2018; 11(2): 297.     CrossRef
  • Iodine-131

    Reactions Weekly.2016; 1617(1): 140.     CrossRef
  • 16,108 View
  • 153 Download
  • 4 Web of Science
  • Crossref
Review

Drug induced liver injury

Factors affecting drug-induced liver injury: antithyroid drugs as instances
Reza Heidari, Hossein Niknahad, Akram Jamshidzadeh, Narges Abdoli
Clin Mol Hepatol 2014;20(3):237-248.
Published online September 25, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.3.237

Methimazole and propylthiouracil have been used in the management of hyperthyroidism for more than half a century. However, hepatotoxicity is one of the most deleterious side effects associated with these medications. The mechanism(s) of hepatic injury induced by antithyroid agents is not fully recognized yet. Furthermore, there are no specific tools for predicting the occurrence of hepatotoxicity induced by these drugs. The purpose of this article is to give an overview on possible susceptibility factors in liver injury induced by antithyroid agents. Age, gender, metabolism characteristics, alcohol consumption, underlying diseases, immunologic mechanisms, and drug interactions are involved in enhancing antithyroid drugs-induced hepatic damage. An outline on the clinically used treatments for antithyroid drugs-induced hepatotoxicity and the potential therapeutic strategies found to be effective against this complication are also discussed.

Citations

Citations to this article as recorded by  Crossref logo
  • Methimazole‐induced cholestasis initially obscured by an incidental finding of a large periampullary diverticulum: A case report with reference to the updated RUCAM of 2016
    Salomon Chamay, Ari Alter, Rooshi Parikh, Shivam Khatri, Deepa Budh, Mitchell Spinnell
    JGH Open.2025;[Epub]     CrossRef
  • Propylthiouracil-induced ANCA-associated vasculitis complicated by granulocytopenia and hemophagocytosis: a case report
    Huilin Zhou, Shuchang Lai, Jinyi Chen, Yi Wang, Shasha Fu, Zongcun Chen
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Interplay between endocrine disorders and liver dysfunction: Mechanisms of damage and therapeutic approaches
    Andres M Vargas-Beltran, Samantha M Armendariz-Pineda, Froylan D Martínez-Sánchez, Carolina Martinez-Perez, Aldo Torre, Jacqueline Cordova-Gallardo
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Exploring animal models and in vitro models for liver diseases: a review
    Narendra S. Bhatt, Anilkumar K. Prajapati, Gaurang B. Shah
    Egyptian Liver Journal.2025;[Epub]     CrossRef
  • Research progress on rodent models and its mechanisms of liver injury
    Jingxin Mao, Lihong Tan, Cheng Tian, Wenxiang Wang, Hao Zhang, Zhaojing Zhu, Yan Li
    Life Sciences.2024; 337: 122343.     CrossRef
  • Protective mechanism of Paeoniae Radix Alba against chemical liver injury based on network pharmacology, molecular docking, and in vitro experiments
    Shuangqiao Liu, Xin Liu, Sijia Jiang, Min Fu, Jinxi Hu, Jiaqi Liu, Xiaoxu Fan, Yingtong Feng, Shujing Zhang, Jingxia Wang
    Journal of Traditional Chinese Medical Sciences.2024; 11(1): 55.     CrossRef
  • An Insight into the Approach Taken to Appurtenances Disorders Linked to Mitochondria
    El Bethel Lalthavel Hmar, Sujata Paul, Rofiqul Islam, Hemanta Kumar Sharma
    Biology Bulletin.2024; 51(2): 271.     CrossRef
  • Comparative Analysis of Oxidative Metabolism in Liver in Different Experimental Models of Hypothyroidism: Low Iodine Diet and Anti-Thyroid drug (Methimazole)
    Guzel Maratovna Abdullina, Feliks Khusainovich Kamilov, Valerii Nikolaevich Kozlov, Shamil Narimanovich Galimov, Nailia Timerkhatmullovna Karyagina, Irina Askhatovna Menshikova, Elvira Rafinatovna Bikmetova
    Biomedical and Pharmacology Journal.2024; 17(3): 1963.     CrossRef
  • Unusual Management of a Rare Case of Methimazole-Resistant Graves Disease
    Michael Tang, Bashar Fteiha, Shumei Meng
    JCEM Case Reports.2024;[Epub]     CrossRef
  • Vitamin D alleviates hypothyroidism associated liver dysfunction: Histological and biochemical evidence
    Seyed Hamidreza Rastegar-Moghaddam, Mahsan Akbarian, Arezoo Rajabian, Fatemeh Alipour, Alireza Ebrahimzadeh bideskan, Mahmoud Hosseini
    Heliyon.2023; 9(8): e18860.     CrossRef
  • Case report: Severe cholestatic jaundice associated with hyperthyroidism treated with methimazole
    Xiaoqiang Liu, Boming Xu, Yilin Zeng, Peizhong Chen, Yubin Wang
    Medicine.2023; 102(45): e35972.     CrossRef
  • Clinical Characteristics and Outcomes of Patients With Antithyroid Drug–Related Liver Injury
    Adeel Ahmad Khan, Fateen Ata, Afia Aziz, Hana Elamin, Aamir Shahzad, Zohaib Yousaf, Anthony Donato
    Journal of the Endocrine Society.2023;[Epub]     CrossRef
  • Advances in the Study of Related Factors of Methimazole-Induced Liver Injury
    丽芹 张
    Advances in Clinical Medicine.2022; 12(10): 9020.     CrossRef
  • Approach to the Patient: Management and the Long-term Consequences of Graves' Disease in Children
    Scott A Rivkees
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(12): 3408.     CrossRef
  • Identification of Drug-Induced Liver Injury Biomarkers from Multiple Microarrays Based on Machine Learning and Bioinformatics Analysis
    Kaiyue Wang, Lin Zhang, Lixia Li, Yi Wang, Xinqin Zhong, Chunyu Hou, Yuqi Zhang, Congying Sun, Qian Zhou, Xiaoying Wang
    International Journal of Molecular Sciences.2022; 23(19): 11945.     CrossRef
  • Comparison of long‐term antithyroid drugs versus radioactive iodine or surgery for Graves' disease: A review of the literature
    Omar M. El Kawkgi, Douglas S. Ross, Marius N. Stan
    Clinical Endocrinology.2021; 95(1): 3.     CrossRef
  • Management of Feline Hyperthyroidism and the Need to Prevent Oxidative Stress: What Can We Learn from Human Research?
    Alessia Candellone, Vittorio Saettone, Paola Badino, Flavia Girolami, Elisabetta Radice, Domenico Bergero, Rosangela Odore, Giorgia Meineri
    Antioxidants.2021; 10(9): 1496.     CrossRef
  • Protective Effect of Natural Antioxidant Compounds on Methimazole Induced Oxidative Stress in a Feline Kidney Epithelial Cell Line (CRFK)
    Flavia Girolami, Alessia Candellone, Watanya Jarriyawattanachaikul, Giorgia Meineri, Carlo Nebbia, Paola Badino
    Veterinary Sciences.2021; 8(10): 220.     CrossRef
  • Die Schilddrüse im Alter
    Christina Tugendsam, Amir Kurtaran
    Wiener Medizinische Wochenschrift.2020; 170(15-16): 410.     CrossRef
  • Maternal Graves Disease and Abnormal CYP2D6 Genotype with Fetal Hyperthyroidism
    Christopher Spoke, Christopher Martin
    AACE Clinical Case Reports.2020; 6(4): e161.     CrossRef
  • Propylthiouracil-induced histological changes in the placenta of swiss albino mice
    Samta Tiwari, SK Pandey
    National Journal of Clinical Anatomy.2020; 9(3): 108.     CrossRef
  • Exacerbated liver injury of antithyroid drugs in endotoxin-treated mice
    Reza Heidari, Fatemeh Ahmadi, Hamid Reza Rahimi, Negar Azarpira, Massood Hosseinzadeh, Asma Najibi, Hossein Niknahad
    Drug and Chemical Toxicology.2019; 42(6): 615.     CrossRef
  • Research Progress on the Animal Models of Drug-Induced Liver Injury: Current Status and Further Perspectives
    Yingying Pan, Mingzhu Cao, Danming You, Genggeng Qin, Zhi Liu
    BioMed Research International.2019; 2019: 1.     CrossRef
  • Boldine Supplementation Regulates Mitochondrial Function and Oxidative Stress in a Rat Model of Hepatotoxicity
    Reza Heidari, Mohammad Reza Arabnezhad, Mohammad Mehdi Ommati, Negar Azarpira, Elham Ghodsimanesh, Hossein Niknahad
    Pharmaceutical Sciences.2019; 25(1): 1.     CrossRef
  • Redox unbalance in the hyperthyroid cat: a comparison with healthy and non-thyroidal diseased cats
    Alessia Candellone, Paola Gianella, Lara Ceccarelli, Graziella Raviri, Paola Badino, Silvia Roncone, Hans S. Kooistra, Giorgia Meineri
    BMC Veterinary Research.2019;[Epub]     CrossRef
  • Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole‐induced liver injury
    Shasha Jin, Xuesong Li, Yujuan Fan, Xiaofang Fan, Yu Dai, Haishu Lin, Weimin Cai, Jialin Yang, Xiaoqiang Xiang
    Basic & Clinical Pharmacology & Toxicology.2019; 125(6): 508.     CrossRef
  • Evaluation of Antioxidant Supplementation on Redox Unbalance in Hyperthyroid Cats Treated with Methimazole: A Blinded Randomized Controlled Trial
    Alessia Candellone, Paola Badino, Paola Gianella, Flavia Girolami, Graziella Raviri, Vittorio Saettone, Giorgia Meineri
    Antioxidants.2019; 9(1): 15.     CrossRef
  • Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies
    Fernando Gomez-Peralta, Pablo Velasco-Martínez, Cristina Abreu, María Cepeda, Marta Fernández-Puente
    Endocrinology, Diabetes & Metabolism Case Reports.2018;[Epub]     CrossRef
  • Impact of cell types and culture methods on the functionality of in vitro liver systems – A review of cell systems for hepatotoxicity assessment
    Jonathan A. Kyffin, Parveen Sharma, Joseph Leedale, Helen E. Colley, Craig Murdoch, Pratibha Mistry, Steven D. Webb
    Toxicology in Vitro.2018; 48: 262.     CrossRef
  • Effect of Goiter Dispersion Formula on Serum Cytokines in Hyperthyroidism Patients with Neurologic Manifestations of Graves' Disease: A Randomized Trial on 80 Cases
    Wen-Hong Tian, Ying Wang, Rui Yang, Hai-Bing Hu
    The Journal of Alternative and Complementary Medicine.2018; 24(5): 481.     CrossRef
  • Betaine treatment protects liver through regulating mitochondrial function and counteracting oxidative stress in acute and chronic animal models of hepatic injury
    Reza Heidari, Hossein Niknahad, Ala Sadeghi, Hamidreza Mohammadi, Vahid Ghanbarinejad, Mohammad Mehdi Ommati, Arghavan Hosseini, Negar Azarpira, Forouzan Khodaei, Omid Farshad, Elaheh Rashidi, Asma Siavashpour, Asma Najibi, Asrin Ahmadi, Akram Jamshidzade
    Biomedicine & Pharmacotherapy.2018; 103: 75.     CrossRef
  • Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice
    Guihua Wang, Bo He, Wen Hu, Kexin Liu, Xiaohan Gong, Hao Kou, Yu Guo, Hui Wang
    Toxicology.2018; 408: 70.     CrossRef
  • The Opportunities of Metabolomics in Drug Safety Evaluation
    Pengcheng Wang, Amina I. Shehu, Xiaochao Ma
    Current Pharmacology Reports.2017; 3(1): 10.     CrossRef
  • Incidence of abnormal liver biochemical tests in hyperthyroidism
    Tiffany Y. Lin, Anshula O. Shekar, Ning Li, Michael W. Yeh, Sammy Saab, Mark Wilson, Angela M. Leung
    Clinical Endocrinology.2017; 86(5): 755.     CrossRef
  • Propylthiouracil-induced mitochondrial dysfunction in liver and its relevance to drug-induced hepatotoxicity
    Akram Jamshidzadeh, Hossein Niknahad, Reza Heidari, Maryam Azadbakht, Forouzan Khodaei, Mohammad Reza Arabnezhad, Omid Farshad
    Pharmaceutical Sciences.2017; 23(2): 95.     CrossRef
  • Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy
    Silvijus Abramavicius, Dzilda Velickiene, Edmundas Kadusevicius
    Medicine.2017; 96(39): e8159.     CrossRef
  • Kupffer cell‐mediated exacerbation of methimazole‐induced acute liver injury in rats
    Sho Akai, Yasuaki Uematsu, Koichi Tsuneyama, Shingo Oda, Tsuyoshi Yokoi
    Journal of Applied Toxicology.2016; 36(5): 702.     CrossRef
  • Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver
    Reza Heidari, Neda Esmailie, Negar Azarpira, Asma Najibi, Hossein Niknahad
    Toxicological Research.2016; 32(2): 133.     CrossRef
  • Drug-induced liver injury caused by iodine-131
    Chei Won Kim, Ji Sun Park, Se Hwan Oh, Jae-Hyung Park, Hyun-Ik Shim, Jae Woong Yoon, Jin Seok Park, Seong Bin Hong, Jun Mi Kim, Trong Binh Le, Jin Woo Lee
    Clinical and Molecular Hepatology.2016; 22(2): 272.     CrossRef
  • Hyperthyroidism Improves the Pathological Condition of Nonalcoholic Steatohepatitis: A Case of Nonalcoholic Steatohepatitis with Graves' Disease
    Teruki Miyake, Bunzo Matsuura, Shinya Furukawa, Yasuhiko Todo, Shin Yamamoto, Osamu Yoshida, Yusuke Imai, Takao Watanabe, Yasunori Yamamoto, Masashi Hirooka, Yoshio Tokumoto, Teru Kumagi, Masanori Abe, Hirotaka Seike, Shozo Miyauchi, Yoichi Hiasa
    Internal Medicine.2016; 55(15): 2019.     CrossRef
  • Paradoxical effect of methimazole on liver mitochondria: In vitro and in vivo
    Hossein Niknahad, Akram Jamshidzadeh, Reza Heidari, Zeynab Hosseini, Keivan Mobini, Forouzan Khodaei, Mohammad Mehdi Ommati, Narges Abdoli, Nahid Keshavarz, Mandana Bazyari, Asma Najibi
    Toxicology Letters.2016; 259: 108.     CrossRef
  • Serial Changes of Liver Function Tests before and during Methimazole Treatment in Thyrotoxic Patients
    Dan Alexandru Niculescu, Roxana Dusceac, Simona Andreea Galoiu, Cristina Ana-Maria Capatina, Catalina Poiana
    Endocrine Practice.2016; 22(8): 974.     CrossRef
  • The Postulated Hepatotoxic Metabolite of Methimazole Causes Mitochondrial Dysfunction and Energy Metabolism Disturbances in Liver
    Hossein Niknahad, Akram Jamshidzadeh, Reza Heidari, Narges Abdoli, Mohammad Mehdi Ommati, Faezeh Jafari, Mahdi Zarei, Behnam Asadi
    Pharmaceutical Sciences.2016; 22(4): 217.     CrossRef
  • Carbonyl Traps as Potential Protective Agents against Methimazole‑Induced Liver Injury
    Reza Heidari, Hossein Niknahad, Akram Jamshidzadeh, Negar Azarpira, Mandana Bazyari, Asma Najibi
    Journal of Biochemical and Molecular Toxicology.2015; 29(4): 173.     CrossRef
  • Propylthiouracil-Induced Liver Injury in Mice and the Protective Role of Taurine
    Raziyeh Karamikhah, Akram Jamshidzadeh, Negar Azarpira, Arastoo Saeidi, Reza Heidari
    Pharmaceutical Sciences.2015; 21(2): 94.     CrossRef
  • Sulfasalazine-Induced Hepatic Injury in an Ex Vivo Model of Isolated Perfused Rat Liver and the Protective Role of Taurine
    Reza Heidari, Nazanin Sadeghi, Negar Azarpira, Hossein Niknahad
    Pharmaceutical Sciences.2015; 21(4): 211.     CrossRef
  • Factors Predicting Abnormal Liver Function Tests Induced by Graves’ Disease Alone
    Ruiguo Zhang, Xun Tian, Lan Qin, Xiaoer Wei, Junqi Wang, Jie Shen
    Medicine.2015; 94(19): e839.     CrossRef
  • Cellular and Molecular Aspects of Drug-Induced Liver Toxicity: Recent Prominent Mechanisms
    Pinar Erkekoglu
    MOJ Toxicology.2015;[Epub]     CrossRef
  • 25,599 View
  • 355 Download
  • 43 Web of Science
  • Crossref